Gradientech closes $2.2M Equity Funding Round
Uppsala Sweden, August 30, 2018. The Swedish biotech and diagnostics firm Gradientech has successfully raised 20 MSEK ($2.2M) in equity funding among its existing investors.Gradientech is a privately owned company developing the in vitro diagnostic (IVD) QuickMIC™ system, a promising platform based on phenotypic bacteria growth analysis. The system is expected to become the most rapid solution for diagnosing appropriate antibiotic treatment of sepsis patients. Rapid antibiotic susceptibility testing is considered essential for increasing sepsis patient survival, especially in the global